{"id":55867,"date":"2024-02-07T05:43:51","date_gmt":"2024-02-07T05:43:51","guid":{"rendered":"https:\/\/medsname.com\/alphagan-p-drop\/"},"modified":"2026-04-30T10:24:43","modified_gmt":"2026-04-30T10:24:43","slug":"alphagan-p-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/alphagan-p-drop\/","title":{"rendered":"Pic\u0103turi Alphagan P"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 R\u0103spuns rapid \u2014 Ce sunt pic\u0103turile Alphagan P?<\/h3>\n

Pic\u0103turile Alphagan P con\u021bin brimonidin\u0103 0,15%, un agonist adrenergic alfa-2 care reduce presiunea intraocular\u0103 cu ~20% prin reducerea produc\u021biei de umoare apoas\u0103 \u0218I cre\u0219terea debitului uveoscleral. Dozaj de trei ori pe zi. Precau\u021bie la copii \u2014 evita\u021bi la v\u00e2rsta < 2 ani (risc de apnee).<\/p>\n<\/div>\n

De ce s\u0103 comanzi de la MedsBase?<\/strong> Produs de un produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate ale clien\u021bilor<\/a><\/div>\n

\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n

De ce s\u0103 comanzi de la MedsBase<\/h3>\n

Pic\u0103turile Alphagan P sunt procurate de la un produc\u0103tor certificat WHO-GMP \u0219i expediate \u00een \u00eentreaga lume \u00een ambalaje discrete \u0219i simple. Fiecare comand\u0103 este acoperit\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> \u2014 dac\u0103 nu a sosit \u00een 20 de zile lucr\u0103toare, expediem din nou f\u0103r\u0103 costuri suplimentare. Sus\u021binut de peste 1.400 de recenzii verificate.<\/p>\n

Ce sunt pic\u0103turile Alphagan P?<\/h2>\n

Pic\u0103turile Alphagan P sunt fabricate de Allergan \u0219i con\u021bin tartrat de brimonidin\u0103 0,15% ca solu\u021bie oftalmic\u0103 steril\u0103. Brimonidina este un agonist adrenergic alfa-2 foarte selectiv utilizat pentru reducerea PIO \u00een glaucomul cu unghi deschis \u0219i hipertensiunea ocular\u0103. Are un mecanism dual unic \u2014 reduce produc\u021bia de umoare apoas\u0103 \u0218I cre\u0219te debitul uveoscleral \u2014 \u0219i este una dintre pu\u021binele pic\u0103turi pentru glaucom cu un posibil efect neuroprotector asupra celulelor ganglionare retiniene, sugerat de dovezi de laborator \u0219i clinice pe cohorte mici.<\/p>\n

Cum func\u021bioneaz\u0103<\/h2>\n

Brimonidina activeaz\u0103 receptorii alfa-2 pe corpul ciliar, sc\u0103z\u00e2nd cAMP \u0219i reduc\u00e2nd produc\u021bia de umoare apoas\u0103. De asemenea, cre\u0219te debitul uveoscleral. Reducerea medie a PIO este de 18\u201322%. Formularea de 0,15% (Alphagan P) utilizeaz\u0103 un sistem de conservare Purite care se descompune \u00een filmul lacrimal \u00een ap\u0103, oxigen \u0219i ioni de clor, f\u0103c\u00e2ndu-l mai bl\u00e2nd dec\u00e2t clorura de benzalconiu pentru utilizare pe termen lung.<\/p>\n

Indica\u021bii & Dozare<\/h2>\n\n\n\n\n\n\n\n
Indica\u021bie<\/th>\nDoza<\/th>\n<\/tr>\n<\/thead>\n
Glaucom cu unghi deschis \/ hipertensiune ocular\u0103<\/td>\n1 pic\u0103tur\u0103 \u00een ochiul (ochii) afectat(e) de trei ori pe zi (la fiecare 8 ore)<\/td>\n<\/tr>\n
Terapie adjunctiv\u0103<\/td>\nDe dou\u0103 ori pe zi<\/td>\n<\/tr>\n
Profilaxia cre\u0219terii PIO post-laser (LPI, SLT)<\/td>\n1 pic\u0103tur\u0103 \u00eenainte de procedur\u0103 \u0219i 1 pic\u0103tur\u0103 dup\u0103 procedur\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
Apnee pediatric\u0103 \u2014 evita\u021bi la copiii < 2 ani.<\/strong> Brimonidina traverseaz\u0103 cu u\u0219urin\u021b\u0103 bariera hemato-encefalic\u0103. La copiii sub 2 ani, chiar \u0219i brimonidina oftalmic\u0103 a provocat depresie CNS care pune via\u021ba \u00een pericol, cu apnee, bradicardie \u0219i hipotensiune. Evita\u021bi la v\u00e2rsta < 2 ani; utiliza\u021bi cu extrem\u0103 pruden\u021b\u0103 la v\u00e2rsta de 2\u20136 ani (doar formularea Alphagan P 0,1%, cu supraveghere \u0219i observare parental\u0103).<\/div>\n

Efecte Secundare<\/h2>\n

Local (10\u201320%):<\/strong> hiperemie conjunctival\u0103, conjunctivit\u0103 alergic\u0103 (apare de obicei la 6\u201318 luni \u2014 caracteristic\u0103 apari\u021bie tardiv\u0103), conjunctivit\u0103 folicular\u0103, prurit ocular, senza\u021bie de corp str\u0103in, vedere \u00eence\u021bo\u0219at\u0103.<\/p>\n

Sistemic:<\/strong> gur\u0103 uscat\u0103, oboseal\u0103, somnolen\u021b\u0103, cefalee, hipotensiune. Copiii (\u00een special sub 6 ani) pot dezvolta somnolen\u021b\u0103 \u0219i bradicardie.<\/p>\n

Avertismente & Contraindica\u021bii<\/h2>\n